Category: Child survival
-
Women driving REACH impact, through science, education, and technology
#FEBRUARY11 On the International Day of Women and Girls in Science, the REACH Network is proud to celebrate women whose scientific expertise, technical leadership, and operational excellence drive its mission to reduce preventable child mortality across Africa. The REACH Network’s work – delivering integrated azithromycin interventions to reduce mortality rates among children aged 1-59 months…
-
REACH on World NTD Day: Integrated, country-led action, to cover every last kilometre
30 January 2025 On World Neglected Tropical Diseases (NTD) Day, the REACH Network is proud to join partners and colleagues across the globe to spotlight a shared mission: reaching children and communities too often left behind, and left out of the systems that seek to deliver good health for all. The burden of NTDs falls…
-
LAKANA study publishes findings in major journal, strengthening understanding of azithromycin’s role in child survival
—
published by
3 November 2025 The REACH Network warmly congratulates the LAKANA study team on the publication of their results in the New England Journal of Medicine. The paper, “Mass Azithromycin Provision for Infants in Mali and Survival,” is the culmination of years of collaboration between researchers, field teams, policymakers, and communities across Mali, all united in…
-
REACH Network expands supplier base to improve access to lifesaving antibiotics for child survival campaigns
The REACH Network and its supply chain partners, the International Trachoma Initiative (ITI) and the Partnership for Supply Chain Management (PFSCM), are pleased to announce an expansion to the global supply base of azithromycin for child survival. Aurobindo Pharma Limited, a manufacturer based in Hyderabad, India, has now been officially recognized as a second supplier…
-
-
REACH approved for national scale-up in Burkina Faso
Ouagadougou, August 2025 The Government of Burkina Faso has announced a major step forward in its fight against preventable child mortality, as the integrated REACH intervention is rolled out across the country. Building on the success of the MIRAMA project, the Ministry of Health will now expand the REACH intervention, which includes mass drug administration…
-
REACH Network and ITI launch new Advisory Panel to strengthen azithromycin stewardship for child survival
—
published by
Atlanta, USA, & Bamako, Mali – 12 August 2025 The REACH Network and the International Trachoma Initiative (ITI) are pleased to announce the launch of the Advisory Panel on Azithromycin for Child Survival (APACS), a new independent body established to provide expert guidance on the responsible and effective use of azithromycin to help reduce…
-
“Greater impact and trust, reduced costs”: making the case for REACH integration at the Maputo Child Survival Forum
—
published by
As global health leaders gathered in Maputo, Mozambique, for the 2025 Innovation and Action for Immunization and Child Survival Forum, the REACH Network delivered a key message: We must integrate and cooperate – do more, differently – in order to give children in the most vulnerable settings a fair chance to survive and thrive. Dr…
-
AVENIR II completes third cycle of MDA in Agadez and Dosso regions
Between 21 and 25 June 2025, the AVENIR project team successfully completed the third round of mass distribution of azithromycin (MDA) in the Agadez and Dosso regions. This campaign, part of AVENIR’s Phase II REACH project, was preceded by the usual preparatory activities: meetings with local authorities and training for community health workers, to ensure…